The concentrations of soluble HLA-G protein are elevated during mid-gestation and decreased in pre-eclampsia

Folia Histochemica et Cytobiologica

Volumn 50, Issue 2, 2012, Pages 286-291

  Darmochwal Kolarz, Dorota ^a   Kolarz, Bogdan ^a   Rolinski, Jacek ^a   Leszczynska Gorzelak, Bozena ^a   Oleszczuk, Jan ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Pre eclampsia; Pregnancy; sHLA G

Indexed keywords

BILIRUBIN; CREATININE; FIBRINOGEN; HLA G ANTIGEN; URIC ACID;

ADULT; ANTIBODY BLOOD LEVEL; ANTIGEN DETECTION; ANTIGEN FUNCTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS WEIGHT; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HUMAN; MATERNAL AGE; PARITY; PATHOGENESIS; PREECLAMPSIA; PROTEINURIA; SECOND TRIMESTER PREGNANCY; SYSTOLIC BLOOD PRESSURE; THIRD TRIMESTER PREGNANCY; UPREGULATION;

EID: 84863874438     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2012.0023     Document Type: Article

References (41)

1. Goodburn E, Cambell O. Reducing maternal mortality in the developing world: sector-wide approaches may be the key. Br Med J. 2001;322:917-920.
2. Hill K, AbouZahr C, Wardlaw T. Estimates of maternal mortality for 1995. Bull World Health Organ. 2001;79:182-193.
3. Norris M, Perico N, Remuzzi G. Mechanism of the disease: pre-eclampsia. Nat Nephrol. 2005;1:98-114.
4. Redman CW. Immunological aspects of pre-eclampsia. Baillieres Clin Obstet Gynaecol. 1992;6:601-615.
5. Darmochwal-Kolarz D, Rolinski J, Tabarkiewicz J, Leszczynska- Gorzelak B, Buczkowski J. Myeloid and lymphoid dendritic cells in normal pregnancy and pre-eclampsia. Clin Exp Immunol. 2003;132:339-344.
6. Darmochwal-Kolarz D, Saito S, Rolinski J, Tabarkiewicz J, Kolarz B, Leszczynska-Gorzelak B. Activated T Lymphocytes in Pre-Eclampsia. Am J Reprod Immunol. 2007;58:39-45.
7. Sacks GP, Studena K, Sargent IL, Redman CWG. Normal pregnancy and pre-eclampsia both pro duce inflammatory chan ges in peripheral blond leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998;179:80-86.
8. Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol Aspects Med. 2007;28:192-209.
9. Darmochwal-Kolarz D, Leszczynska-Gorzelak B, Rolinski J, Oleszczuk J. T helper 1- and T helper 2-type cytokine imbalance in pregnant women with pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 1999 86:165-1670.
10. Carosella ED, Moreau P, Le Maoult J, Le'Discorde M, Dausset J, Rouass-Freiss N. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol. 2003;81:199-252.
11. O'Brien M, Dausset J, Carosella ED, Moreau P. Analysis of the role of HLA-G in preeclampsia. Hum Immunol. 2000;61:1126-1131.
12. Markert UR. Immunology of pregnancy. In: Clinical Immunology and Allergy. S. Karger, AG, Basel, Switzerland.
13. Hackmon R, Hallak M, Krup M et al. HLA-G Antigen and Parturition: Maternal Serum, Fetal Serum and Amniotic Fluid Levels during Pregnancy. Fetal Diagn Ther. 2004;19:404-409.
14. Le Bouteiller P, Solier C, Pröll J, Aguerre-Girr M, Fournel S, Lenfant F. Placental HLA-G protein expression in vivo: where and what for? Hum Reprod Update. 1999;5:223-233.
15. Le Discorde M, Moreau P, Rouas-Freiss N, Carosella E. HLA-G: immune tolerance in normal and pathological physiology. Pathol Biol. 2002;50:45-51.
16. Pistoia V, Morandi F, Wang X, Ferrone S. Soluble HLA-G: are they clinically relevant? Semin Cancer Biol. 2007;17:469-479.
17. Hunt JS, Pace JL, Morales PJ, Ober C. Immunogenicity of the soluble isoforms of HLA-G. Mol Hum Reprod. 2003;9:729-735.
18. Colbern GT, Chiang MH, Main EK. Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta. Am J Obstet Gynecol. 1994;170:1244-1250.
19. Hackmon R, Koifman A, Hyobo H, Glickman H, Sheiner E, Geraghty DE. Reduced third-trimester of soluble human leukocyte antigen G protein in severe preeclampsia. Am J Obstet Gynecol. 2007;197:255.e1-5.
20. Desai N, Filipovits J, Singh P, Beman M, Goldfarb J. Assessment of soluble HLA-G levels in day 3 human embryo culture media using a new ELISA kit: Is there a relationship to embryo quality, development and implantation potential? Fertil Steril. 2005; 84:281-282.
21. Steinborn A, Varkonyi T, Scharf A, Bahlmann F, Klee A, Sohn C. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am J Reprod Immunol. 2007;57:277-286.
22. Colbern GT, Chiang MH, Main EK. Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta. Am J Obstet Gynecol. 1994;170:1244-1250.
23. Alegre E, Díaz-Lagares A, Lemaoult J, López-Moratalla N, Carosella ED, González A. Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: Longitudinal study during pregnancy. Hum Immunol. 2007;68:661-667.
24. Vianna P, Dalmáz CA, Veit TD, Tedoldi C, Roisenberg I, Chies JA. Immunogenetics of pregnancy: Role of a 14-bp deletion in the maternal HLA-G gene in primiparous preeclamptic Brazilian women. Hum Immunol. 2007;68:668-674.
25. Zavazava N, Krönke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat Med. 1996;2:1005-1010.
26. Hunt JS, Petroff MG, Morales P, Sedlmayr P, Geraghty DE, Ober C. HLA-G in reproduction: studies on the maternal-fetal interface. Hum Immunol. 2000;61:1113-1117.
27. Fournel S, Aguerre-Girr M, Huc X et al. Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol. 2000;164: 6100-6104.
28. Yie SM, Li LH, Li YM, Librach C. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am J Obstet Gynecol. 2004;191:525-529.
29. Noci I, Fuzzi B, Rizzo R et al. Embryonic soluble HLA-G as a marker of developmental potential in embryos. Hum Reprod. 2005;20:138-146.
30. Yie SM, Taylor RN, Librach C. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am J Obstet Gynecol. 2005;193:204-208.
31. Maejima M, Fujii T, Kozuma S, Okai T, Shibata Y, Taketani Y. Presence of HLA-G-expressing cells modulates the ability of peripheral blood mononuclear cells to release cytokines. Am J Reprod Immunol. 1997;38:79-82.
32. Rizzo R, Andersen AS, Lassen MR et al. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy. Am J Reprod Immunol. 2009;62:320-338.
33. Menezo Y, Elder K, Viville S. Soluble HLA-G release by the human embryo: an interesting artifact. Reprod Biomed Online. 2006;13:763-764.
34. + T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients. Eur J Immunol. 2004;34:649-660.
35. Chaouat G. Current knowledge on natural killer cells, pregnancy and pre-eclampsia. Introduction. Reprod Biomed Online. 2008;16:170-172.
36. Le Bouteiller P. The role of HLA-G expression in the embryo during implantation. J Gynecol Obstet Biol Reprod. 2004;33:9-12.
37. Le Bouteiller P, Pizzato N, Barakonyi A, Solier C. HLA-G, pre-eclampsia, immunity and vascular events. J Reprod Immunol. 2003;59:219-234.
38. Santoni A, Carlino C, Stabile H, Gismondi A. Mechanisms underlying recruitment and accumulation of decidual NK cells in uterus during pregnancy. Am J Reprod Immunol. 2008;59:417-424.
39. Santoni A, Carlino C, Gismondi A. Uterine NK cell development, migration and function. Reprod Biomed Online. 2008;16:202-210.
40. Rajagopalan S, Long EO. Antagonizing inhibition gets NK cells going. Proc Natl Acad Sci USA. 2010;107:10333-10334.
41. Hunt JS, Morales PJ, Pace JL, Fazleabas AT, Langat DK. A commentary on gestational programming and functions of HLA-G in pregnancy. Placenta. 2007;28:57-63.